BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Lupin to acquire VISUfarma for €190 mn to strengthen ophthalmology

Synopsis:


Lupin, through its subsidiary Nanomi B.V., has signed a definitive agreement to acquire VISUfarma B.V. for €190 mn. The deal expands Lupin’s specialty ophthalmology business across Europe, adding over 60 eye care products and a presence in five key markets.


Source:
Lupin Press Release (NSE Exchange Fillings) | Published on Sept 29, 2025

Disclaimer: This content has been published for informational purposes only. Bajaj Broking is not affiliated with, nor does it endorse or assume any responsibility for, the source material. Readers are advised to consult the original publication for complete and accurate context.

Lupin news today

As quoted in the press release of Lupin (NSE Exchange Filings), the company said that its wholly-owned subsidiary, Nanomi B.V., has entered into a definitive agreement to acquire VISUfarma B.V., a Netherlands-based specialty pharmaceutical company focused in ophthalmology, for an enterprise value of €190 million.                             

The transaction will be funded utilizing cash on Lupin's balance sheet and is expected to close by the end of 2025, pending certain regulatory approvals. VISUfarma has a diversified portfolio of over 60 branded eye health products and maintains a strong presence across major European markets in Italy, the United Kingdom, Spain, Germany, and France. 

Also read: Jindal Steel commissions 5 MTPA blast furnace at Angul plant

LUPIN LIMITED

Trade

1933.213.39 (0.69 %)

Updated - 29 September 2025
1958.00day high
DAY HIGH
1920.20day low
DAY LOW
1513775
VOLUME (BSE)

Key Takeaways

  • Nanomi B.V., Lupin’s subsidiary, will acquire 100% of VISUfarma B.V. for €190 million.

  • VISUfarma operates across Italy, the UK, Spain, Germany, and France with over 60 ophthalmology products.

  • The acquisition expands Lupin’s specialty business and strengthens its global presence.

  • VISUfarma reported a turnover of €48.1 million and net worth of €134.6 million in 2024.

  • Completion of the transaction is expected by the end of 2025.

Also read: PG Electroplast acquires 50-acre land in Sri City for plant buildout

Deal structure and business overview

Particulars

Details

Target Company

VISUfarma B.V.

Acquirer

Nanomi B.V. (wholly owned subsidiary of Lupin)

Industry

Specialty pharmaceuticals (ophthalmology)

Enterprise Value

€190 million

Shareholding Acquired

100%

Product Portfolio

60+ branded ophthalmology products

Key Markets

Italy, UK, Spain, Germany, France

FY24 Turnover

€48.1 million

Expected Deal Closure

End of 2025

Strategic Rationale

Expansion of specialty segment and European footprint

Business impact and market outlook

In 2024, VISUfarma delivered €48.1 million in consolidated revenue and is about to reach a projected figure of €54 million in 2025. With a broad commercial footprint and a deep product portfolio, VISUfarma's acquisition will be meaningful to Lupin's revenue growth and operating margin. 

The global ophthalmology market stands at €28 billion and continues grow steadily, given an aging population, increased incidence of diabetes-related eye conditions, and heightened demand for preventive care. With this acquisition, Lupin is well-positioned to capture a share of this expanding market and diversify its revenue streams beyond generics and traditional therapeutic areas.

Lupin share price update 

As of September 29, 2025, at 11:20 AM IST, Lupin's share price on the BSE is trading at ₹1,950.80, up by 1.61%.

Also read: Azad Engineering wins ₹651 cr Mitsubishi contract

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹6400+ Cr MTF Book

icon-with-text